TY - BOOK AU - Swerdlow, S. H. AU - Campo, E. AU - Harris, N. L. PY - 2008 DA - 2008// TI - World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues PB - IARC Press CY - Lyon ID - Swerdlow2008 ER - TY - JOUR AU - Tse, E. AU - Kwong, Y. L. PY - 2017 DA - 2017// TI - The diagnosis and management of NK/T-cell lymphomas JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0452-9 DO - 10.1186/s13045-017-0452-9 ID - Tse2017 ER - TY - JOUR AU - Au, W. Y. AU - Pang, A. AU - Choy, C. AU - Chim, C. S. AU - Kwong, Y. L. PY - 2004 DA - 2004// TI - Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients JO - Blood. VL - 104 UR - https://doi.org/10.1182/blood-2003-12-4197 DO - 10.1182/blood-2003-12-4197 ID - Au2004 ER - TY - JOUR AU - Cai, Q. AU - Cai, J. AU - Fang, Y. AU - Young, K. H. PY - 2019 DA - 2019// TI - Epstein-Barr virus-positive natural killer/T-cell lymphoma JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.00386 DO - 10.3389/fonc.2019.00386 ID - Cai2019 ER - TY - JOUR AU - Lee, J. AU - Park, Y. H. AU - Kim, W. S. PY - 2005 DA - 2005// TI - Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy JO - Eur J Cancer VL - 41 UR - https://doi.org/10.1016/j.ejca.2005.03.010 DO - 10.1016/j.ejca.2005.03.010 ID - Lee2005 ER - TY - JOUR AU - Chim, C. S. AU - Ma, S. Y. AU - Au, W. Y. PY - 2004 DA - 2004// TI - Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index JO - Blood VL - 103 UR - https://doi.org/10.1182/blood-2003-05-1401 DO - 10.1182/blood-2003-05-1401 ID - Chim2004 ER - TY - JOUR AU - Kwong, Y. L. AU - Kim, W. S. AU - Lim, S. T. PY - 2012 DA - 2012// TI - SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group JO - Blood. VL - 120 UR - https://doi.org/10.1182/blood-2012-05-431460 DO - 10.1182/blood-2012-05-431460 ID - Kwong2012 ER - TY - JOUR AU - Yamaguchi, M. AU - Kwong, Y. L. AU - Kim, W. S. PY - 2011 DA - 2011// TI - Phase II Study of SMILE chemotherapy for newly diagnosed stave IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.6287 DO - 10.1200/JCO.2011.35.6287 ID - Yamaguchi2011 ER - TY - JOUR AU - Ahn, H. K. AU - Kim, S. J. AU - Hwang, D. W. AU - Ko, Y. H. AU - Tang, T. AU - Lim, S. T. AU - Kim, W. S. PY - 2013 DA - 2013// TI - Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma JO - Investig New Drugs VL - 31 UR - https://doi.org/10.1007/s10637-012-9889-4 DO - 10.1007/s10637-012-9889-4 ID - Ahn2013 ER - TY - JOUR AU - Kim, W. Y. AU - Nam, S. J. AU - Kim, S. AU - Kim, T. M. AU - Heo, D. S. AU - Kim, C. W. AU - Jeon, Y. K. PY - 2015 DA - 2015// TI - Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.974048 DO - 10.3109/10428194.2014.974048 ID - Kim2015 ER - TY - JOUR AU - Hui, J. AU - Przespo, E. AU - Elefante, A. PY - 2012 DA - 2012// TI - Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses JO - J Oncol Pharm Pract VL - 18 UR - https://doi.org/10.1177/1078155211420605 DO - 10.1177/1078155211420605 ID - Hui2012 ER - TY - JOUR AU - O'Connor, O. A. AU - Pro, B. AU - Pinter-Brown, L. PY - 2011 DA - 2011// TI - Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.29.9024 DO - 10.1200/JCO.2010.29.9024 ID - O'Connor2011 ER - TY - JOUR AU - Tse, E. AU - Chan, T. S. AU - Koh, L. P. PY - 2014 DA - 2014// TI - Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group JO - Bone Marrow Transplant VL - 49 UR - https://doi.org/10.1038/bmt.2014.65 DO - 10.1038/bmt.2014.65 ID - Tse2014 ER - TY - JOUR AU - Kanate, A. S. AU - DiGilio, A. AU - Ahn, K. W. PY - 2017 DA - 2017// TI - Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis JO - Br J Haematol VL - 182 UR - https://doi.org/10.1111/bjh.14879 DO - 10.1111/bjh.14879 ID - Kanate2017 ER - TY - JOUR AU - Kharfan-Dabaja, M. A. AU - Kumar, A. AU - Ayala, E. PY - 2017 DA - 2017// TI - Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation JO - Biol Blood Marrow Transplant VL - 23 UR - https://doi.org/10.1016/j.bbmt.2017.07.027 DO - 10.1016/j.bbmt.2017.07.027 ID - Kharfan-Dabaja2017 ER - TY - JOUR AU - Kim, S. J. AU - Yoon, D. H. AU - Jaccard, A. PY - 2016 DA - 2016// TI - A prognostic index for natural killer/T-cell lymphoma after non-anthracycline-based treatment: a multicenter, retrospective analysis JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(15)00533-1 DO - 10.1016/S1470-2045(15)00533-1 ID - Kim2016 ER - TY - JOUR AU - Wang, L. AU - Wang, H. AU - Wang, J. H. PY - 2015 DA - 2015// TI - Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase JO - Oncotarget. VL - 6 ID - Wang2015 ER - TY - JOUR AU - Kwong, Y. L. AU - Pang, A. W. AU - Leung, A. Y. AU - Chim, C. S. AU - Tse, E. PY - 2014 DA - 2014// TI - Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance JO - Leukemia. VL - 28 UR - https://doi.org/10.1038/leu.2013.212 DO - 10.1038/leu.2013.212 ID - Kwong2014 ER -